{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:12:53Z","timestamp":1787026373695,"version":"build-2736575974"},"reference-count":165,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004810","name":"Samfundet Folkh\u00e4lsan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00070","type":"journal-article","created":{"date-parts":[[2019,2,24]],"date-time":"2019-02-24T23:19:11Z","timestamp":1551050351000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":97,"title":["New Insights Into Monogenic Causes of Osteoporosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Riikka E.","family":"M\u00e4kitie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Costantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"K\u00e4mpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.","family":"Alm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Outi","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"421746","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: structure, function, and factors that influence bone cells","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"Biomed Res Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrrheum.2013.45","article-title":"Causes, mechanisms and management of paediatric osteoporosis","volume":"9","author":"M\u00e4kitie","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jbmr.412","article-title":"Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass","volume":"26","author":"Baxter-Jones","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/jbmr.3447","article-title":"Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study.","volume":"33","author":"Ward","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3899\/jrheum.110305","article-title":"Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis","volume":"39","author":"Markula-Patjas","year":"2012","journal-title":"J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/jbmr.2511","article-title":"Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders","volume":"30","author":"LeBlanc","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2018.09.005.","article-title":"Fractures and bone health monitoring in boys with Duchenne muscular dystrophy managed within the Scottish Muscle Network","author":"Joseph","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jamapediatrics.2017.3579","article-title":"Association between inhaled corticosteroid use and bone fracture in children with asthma","volume":"172","author":"Gray","year":"2018","journal-title":"JAMA Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161435.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u22122016","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"key":"B10","first-page":"785","article-title":"NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy. Osteoporosis prevention, diagnosis, and therapy.","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jpeds.2004.10.052","article-title":"Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis","volume":"146","author":"M\u00e4kitie","year":"2005","journal-title":"J Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","article-title":"International Society of Clinical Densitometry. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions.","volume":"17","author":"Bishop","year":"2014","journal-title":"J Clin Densitom"},{"key":"B13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1210\/er.2009-0044","article-title":"Genetics of osteoporosis","volume":"31","author":"Ralston","year":"2010","journal-title":"Endocr Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tem.2016.03.006","article-title":"Osteoporosis and bone mass disorders: from gene pathways to treatments","volume":"27","author":"Rivadeneira","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1056\/NEJMra0808700","article-title":"Genomewide association studies and human disease","volume":"360","author":"Hardy","year":"2009","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/bmb\/ldu042","article-title":"The genetics of osteoporosis","volume":"113","author":"Clark","year":"2015","journal-title":"Br Med Bull"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/ng.3949","article-title":"Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis","volume":"49","author":"Kemp","year":"2017","journal-title":"Nat Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.2249","article-title":"Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture","volume":"44","author":"Estrada","year":"2012","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature14878","article-title":"Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture","volume":"526","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/edrv.23.3.0464","article-title":"Genetics of osteoporosis","volume":"23","author":"Peacock","year":"2002","journal-title":"Endocr Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s00223-014-9852-9","article-title":"Heritability of bone mineral density in a multivariate family-based study","volume":"94","author":"Hernandez-de Sosa","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/jbmr.2604","article-title":"Two rare mutations in the COL1A2 gene associate with low bone mineral density and fractures in Iceland","volume":"31","author":"Styrkarsdottir","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature12124","article-title":"Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits","volume":"497","author":"Styrkarsdottir","year":"2013","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/aje\/kwq234","article-title":"Genome-wide significant associations for variants with minor allele frequency of 5% or less\u2013an overview: a HuGE review","volume":"172","author":"Panagiotou","year":"2010","journal-title":"Am J Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jocd.2017.06.013","article-title":"Overview of fracture prediction tools","volume":"20","author":"Kanis","year":"2017","journal-title":"J Clin Densitom"},{"key":"B26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00198-004-1771-6","article-title":"Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men","volume":"16","author":"Gonnelli","year":"2005","journal-title":"Osteoporos Int"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e000509","DOI":"10.1136\/rmdopen-2017-000509","article-title":"Do we need bone mineral density to estimate osteoporotic fracture risk?","volume":"3","author":"Marques","year":"2017","journal-title":"RMD Open"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1002\/ajmg.a.37365","article-title":"Nosology and classification of genetic skeletal disorders: 2015 revision","author":"Bonafe","year":"2015","journal-title":"Am J Med Genet A"},{"key":"B29","first-page":"49","article-title":"Molecular biology of bone remodelling","volume":"5","author":"Rucci","year":"2008","journal-title":"Clin Cases Miner Bone Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: the OPG\/RANKL\/RANK system","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00198-012-1909-x","article-title":"Osteoblastogenesis regulation signals in bone remodeling","volume":"23","author":"Zuo","year":"2012","journal-title":"Osteoporos Int"},{"key":"B32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12178-009-9046-7","article-title":"RANK, RANKL and osteoprotegerin in bone biology and disease","volume":"2","author":"Wright","year":"2009","journal-title":"Curr Rev Musculoskelet Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrendo.2013.137","article-title":"Osteopetrosis: genetics, treatment and new insights into osteoclast function","volume":"9","author":"Sobacchi","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.metabol.2017.10.007","article-title":"Juvenile Paget disease","volume":"80","author":"Polyzos","year":"2018","journal-title":"Metabolism"},{"key":"B36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3803\/EnM.2013.28.4.255","article-title":"Recent progress in osteocyte research","volume":"28","author":"Divieti Pajevic","year":"2013","journal-title":"Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s11914-017-0373-0","article-title":"Osteocyte mechanobiology","volume":"15","author":"Uda","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrendo.2016.71","article-title":"Osteocytic signalling pathways as therapeutic targets for bone fragility","volume":"12","author":"Plotkin","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.2653","article-title":"Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis","volume":"18","author":"Maeda","year":"2012","journal-title":"Nat Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/bdrc.20195","article-title":"Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases","volume":"90","author":"Sugimura","year":"2010","journal-title":"Birth Defects Res C Embryo Today"},{"key":"B42","first-page":"146","article-title":"Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13","volume":"59","author":"Gong","year":"1996","journal-title":"Am J Hum Genet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"Osteoporosis-Pseudoglioma Syndrome Collaborative Group. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jbspin.2004.10.008","article-title":"LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders","volume":"72","author":"Levasseur","year":"2005","journal-title":"Joint Bone Spine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.bone.2006.11.010","article-title":"The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men","volume":"40","author":"Saarinen","year":"2007","journal-title":"Bone"},{"key":"B46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1359\/JBMR.050101","article-title":"Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children","volume":"20","author":"Hartikka","year":"2005","journal-title":"J Bone Miner Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2265.2009.03680.x","article-title":"Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia","volume":"72","author":"Saarinen","year":"2010","journal-title":"Clin Endocrinol Oxf"},{"key":"B48","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.gep.2008.12.009","article-title":"Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation","volume":"9","author":"Witte","year":"2009","journal-title":"Gene Expr Patterns"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.3654","article-title":"Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures","volume":"20","author":"Mov\u00e9rare-Skrtic","year":"2014","journal-title":"Nat Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1002745","DOI":"10.1371\/journal.pgen.1002745","article-title":"WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk","volume":"8","author":"Zheng","year":"2012","journal-title":"PLoS Genet"},{"key":"B53","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/bonekey.2015.36","article-title":"A new WNT on the bone: WNT16, cortical bone thickness, porosity and fractures","volume":"4","author":"Gori","year":"2015","journal-title":"Bonekey Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1530\/JOE-18-0020","article-title":"Inducible Wnt16 inactivation: WNT16 regulates cortical bone thickness in adult mice","volume":"237","author":"Ohlsson","year":"2018","journal-title":"J Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1215458","article-title":"WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta","volume":"368","author":"Laine","year":"2013","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ajhg.2013.02.009","article-title":"WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta","volume":"92","author":"Pyott","year":"2013","journal-title":"Am J Hum Genet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ajhg.2013.02.010","article-title":"Mutations in WNT1 cause different forms of bone fragility","volume":"92","author":"Keupp","year":"2013","journal-title":"Am J Hum Genet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/jmedgenet-2013-101750","article-title":"WNT1 mutation with recessive osteogenesis imperfecta and profound neurological phenotype","volume":"50","author":"Faqeih","year":"2013","journal-title":"J Med Genet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejmg.2014.10.001","article-title":"Mutations in patients with osteogenesis imperfecta from consanguineous Indian families","volume":"58","author":"Stephen","year":"2015","journal-title":"Eur J Med Genet"},{"key":"B60","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cca.2016.07.012","article-title":"Genotype-phenotype analysis of a rare type of osteogenesis imperfecta in four Chinese families with WNT1 mutations","volume":"461","author":"Liu","year":"2016","journal-title":"Clin Chim Acta"},{"key":"B61","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/jmedgenet-2015-103476","article-title":"Variable brain phenotype primarily affects the brainstem and cerebellum in patients with osteogenesis imperfecta caused by recessive WNT1 mutations","volume":"53","author":"Aldinger","year":"2016","journal-title":"J Med Genet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1002\/jbmr.2841","article-title":"Skeletal characteristics of WNT1 osteoporosis in children and young adults","volume":"31","author":"M\u00e4kitie","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bone.2017.04.001","article-title":"Impaired WNT signaling and the spine\u2013Heterozygous WNT1 mutation causes severe age-related spinal pathology","volume":"101","author":"M\u00e4kitie","year":"2017","journal-title":"Bone"},{"key":"B64","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00198-017-4309-4","article-title":"Defective WNT signaling and bone marrow fibrosis\u2013a cross-sectional study on 10 adults with WNT1 osteoporosis","volume":"29","author":"M\u00e4kitie","year":"2018","journal-title":"Osteoporosis Int"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1056\/NEJMoa1509342","article-title":"Cortical-bone fragility\u2013insights from sFRP4 deficiency in Pyle's disease","volume":"374","author":"Kiper","year":"2016","journal-title":"N Engl J Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/NEJMoa1308223","article-title":"PLS3 mutations in X-linked osteoporosis with fractures","volume":"369","author":"van Dijk","year":"2013","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1002\/jbmr.2208","article-title":"Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics","volume":"29","author":"Fahiminiya","year":"2014","journal-title":"J Bone Mineral Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jbmr.2355","article-title":"A novel splice mutation in PLS3 causes X-linked early onset low-turnover osteoporosis","volume":"30","author":"Laine","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/jbmr.3233","article-title":"PLS3 deletions lead to severe spinal osteoporosis and disturbed bone matrix mineralization","volume":"32","author":"K\u00e4mpe","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1007\/s00198-017-4150-9","article-title":"PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants","volume":"28","author":"K\u00e4mpe","year":"2017","journal-title":"Osteoporos Int"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.jmb.2017.06.021","article-title":"The roles of actin-binding domains 1 and 2 in the calcium-dependent regulation of actin filament bundling by human plastins","volume":"429","author":"Schwebach","year":"2017","journal-title":"J Mol Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy","volume":"320","author":"Oprea","year":"2008","journal-title":"Science"},{"key":"B73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/(SICI)1097-0185(199605)245:1<57::AID-AR10>3.0.CO;2-8","article-title":"Cytoskeletal differences between stereocilia of the human sperm passageway and microvilli\/stereocilia in other locations","volume":"245","author":"H\u00f6fer","year":"1996","journal-title":"Anat Rec"},{"key":"B74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1034\/j.1600-0765.2000.035006335.x","article-title":"Response of periodontal ligament fibroblasts and gingival fibroblasts to pulsating fluid flow: nitric oxide and prostaglandin E2 release and expression of tissue non-specific alkaline phosphatase activity","volume":"35","author":"van der Pauw","year":"2000","journal-title":"J Periodontal Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1359\/jbmr.1998.13.10.1555","article-title":"Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections","volume":"13","author":"Tanaka-Kamioka","year":"1998","journal-title":"J Bone Miner Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1359\/JBMR.040128","article-title":"Terminal differentiation of osteoblasts to osteocytes is accompanied by dramatic changes in the distribution of actin-binding proteins","volume":"19","author":"Kamioka","year":"2004","journal-title":"J Bone Miner Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1096\/fj.05-4966.com","article-title":"Bone cell responses to high-frequency vibration stress: does the nucleus oscillate within the cytoplasm?","volume":"20","author":"Bacabac","year":"2006","journal-title":"FASEB J"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1210\/jc.2017-00099","article-title":"Osteocyte protein expression is altered in low-turnover osteoporosis caused by mutations in WNT1 and PLS3","volume":"102","author":"Wesseling-Perry","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B79","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1210\/jc.2016-2423","article-title":"Teriparatide treatment in patients with WNT1 or PLS3 mutation-related early-onset osteoporosis\u2013a pilot study","volume":"102","author":"V\u00e4lim\u00e4ki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","first-page":"14170","DOI":"10.1073\/pnas.1208916109","article-title":"The role of intracellular calcium phosphate in osteoblast-mediated bone apatite formation","volume":"109","author":"Boonrungsiman","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jprot.2011.04.005","article-title":"Proteomic characterization of biogenesis and functions of matrix vesicles released from mineralizing human osteoblast-like cells","volume":"74","author":"Thouverey","year":"2011","journal-title":"J Proteomics"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.theriogenology.2013.01.028","article-title":"Boar seminal plasma exosomes: effect on sperm function and protein identification by sequencing","volume":"79","author":"Piehl","year":"2013","journal-title":"Theriogenology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1093\/hmg\/ddy318","article-title":"Plastin 3 influences bone homeostasis through regulation of osteoclast activity","volume":"27","author":"Neugebauer","year":"2018","journal-title":"Hum Mol Genet"},{"key":"B84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/B978-0-12-382040-2.10002-4","article-title":"Bone matrix and mineralization","volume-title":"Pediatric Bone","author":"McKee","year":"2012"},{"key":"B85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00198-002-1342-7","article-title":"Bone matrix proteins: their function, regulation, and relationship to osteoporosis","volume":"14","author":"Young","year":"2003","journal-title":"Osteoporos Int"},{"key":"B86","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Dis Primers"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"key":"B88","first-page":"7751","article-title":"Defective folding and stable association with protein disulfide isomerase\/prolyl hydroxylase of type I procollagen with a deletion in the ProaZ(1) chain that preserves theG ly-X-Y repeat","volume":"267","author":"Chessler","year":"1992"},{"key":"B89","doi-asserted-by":"crossref","first-page":"21068","DOI":"10.1074\/jbc.271.35.21068","article-title":"Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB","volume":"271","author":"Mundlos","year":"1996","journal-title":"J Biol Chem"},{"key":"B90","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00223-015-0066-6","article-title":"Osteogenesis imperfecta type I caused by COL1A1 deletions","volume":"98","author":"Bardai","year":"2016","journal-title":"Calcif Tissue Int"},{"key":"B91","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fendo.2018.00380","article-title":"Rare copy number variants in array-based comparative genomic hybridization in early-onset skeletal fragility","volume":"9","author":"Costantini","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00223-018-0414-4","article-title":"Autosomal recessive osteogenesis imperfecta caused by a novel homozygous COL1A2 mutation","volume":"103","author":"Costantini","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"B93","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/jmg.21.4.257","article-title":"The clinical features of homozygous \u00e02(I) collagen deficient osteogenesis imperfecta","volume":"21","author":"Nicholls","year":"1984","journal-title":"J Med Genet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s004390050392","article-title":"Homozygosity by descent for a COL1A2 mutation in two sibs with severe osteogenesis imperfecta and mild clinical expression in the heterozygotes","volume":"99","author":"De","year":"1997","journal-title":"Hum Genet"},{"key":"B95","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1016\/S0021-9258(18)90635-6","article-title":"Osteogenesis imperfecta: cloning of a Pro-a2(I) collagen gene with a frameshift mutation","volume":"259","author":"Pihlajaniemi","year":"1984","journal-title":"J Biol Chem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/humu.21475","article-title":"COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta","volume":"32","author":"Lindahl","year":"2011","journal-title":"Hum Mutat"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/jbmr.3424","article-title":"Mutations that alter the carboxy-terminal-propeptide cleavage site of the chains of type I procollagen are associated with a unique osteogenesis imperfecta phenotype","volume":"33","author":"Cundy","year":"","journal-title":"J Bone Miner Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.ajhg.2015.04.021","article-title":"Recessive osteogenesis imperfecta caused by missense mutations in SPARC","volume":"96","author":"Mendoza-Londono","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.matbio.2016.02.001","article-title":"SPARC\/osteonectin in mineralized tissue","volume":"52","author":"Rosset","year":"2016","journal-title":"Matrix Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0092-8674(81)90037-4","article-title":"Osteonectin, a bone-specific protein linking mineral to collagen","volume":"26","author":"Termine","year":"1981","journal-title":"Cell"},{"key":"B101","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ajhg.2011.01.015","article-title":"Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta","volume":"88","author":"Becker","year":"2011","journal-title":"Am J Hum Genet"},{"key":"B102","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","article-title":"A single recurrent mutation in the 5\u2032-UTR of IFITM5 causes osteogenesis imperfecta type V","volume":"9","author":"Cho","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B103","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jmedgenet-2017-104999","article-title":"FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta","volume":"55","author":"Doyard","year":"2018","journal-title":"J Med Genet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/jbmr.2834","article-title":"Spondyloocular syndrome: novel mutations in XYLT2 gene and expansion of the phenotypic spectrum","volume":"31","author":"Taylan","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ajhg.2015.04.017","article-title":"Homozygosity for frameshift mutations in XYLT2 result in a spondylo-ocular syndrome with bone fragility, cataracts, and hearing defects","volume":"96","author":"Munns","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B106","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1055\/s-0042-118706","article-title":"Abnormal proteoglycan synthesis due to gene defects causes skeletal diseases with overlapping phenotypes","volume":"48","author":"Taylan","year":"2016","journal-title":"Horm Metab Res"},{"key":"B107","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ajhg.2010.05.020","article-title":"FKBP10 and Bruck syndrome: phenotypic heterogeneity or call for reclassification?","volume":"87","author":"Shaheen","year":"2010","journal-title":"Am J Hum Genet"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/dds371","article-title":"Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen","volume":"22","author":"Schwarze","year":"2013","journal-title":"Hum Mol Genet"},{"key":"B109","doi-asserted-by":"publisher","first-page":"40967","DOI":"10.1074\/jbc.M307380200","article-title":"Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis","volume":"278","author":"van der Slot","year":"2003","journal-title":"J Biol Chem"},{"key":"B110","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ajmg.a.30231","article-title":"Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2","volume":"131","author":"Ha-Vinh","year":"2004","journal-title":"Am J Med Genet"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","author":"van Dijk","year":"2014","journal-title":"Am J Med Genet A"},{"key":"B112","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1749-6632.2000.tb06253.x","article-title":"Idiopathic juvenile osteoporosis","volume":"900","author":"Krassas","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000439566","article-title":"New genetic forms of childhood-onset primary osteoporosis","volume":"84","author":"K\u00e4mpe","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"B114","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/nar\/25.1.181","article-title":"The human type I collagen mutation database","volume":"25","author":"Dalgleish","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/nar\/26.1.253","article-title":"The human collagen mutation database 1998","volume":"26","author":"Dalgleish","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"eaal5209","DOI":"10.1126\/scitranslmed.aal5209","article-title":"Improving genetic diagnosis in Mendelian disease with transcriptome sequencing","volume":"9","author":"Cummings","year":"2017","journal-title":"Sci Transl Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"11901","DOI":"10.1073\/pnas.1613365113","article-title":"Deep sequencing of 10,000 human genomes","volume":"113","author":"Telenti","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1210\/jc.2013-1505","article-title":"New genes in bone development: what's new in osteogenesis imperfecta","volume":"98","author":"Marini","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1210\/jc.2017-02585","article-title":"Altered MicroRNA profile in osteoporosis caused by impaired WNT signaling","volume":"103","author":"M\u00e4kitie","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B120","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/EJE-17-0585","article-title":"Diagnosis of endocrine disease: bone turnover markers: are they clinically useful?","volume":"178","author":"Eastell","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.3899\/jrheum.131107","article-title":"High adiposity and serum leptin accompanied by altered bone turnover markers in severe juvenile idiopathic arthritis","volume":"41","author":"Markula-Patjas","year":"2014","journal-title":"J Rheumatol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1210\/jc.2013-3097","article-title":"Suppressed bone turnover in obesity: a link to energy metabolism?","volume":"99","author":"Viljakainen","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B124","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00223-011-9551-8","article-title":"The effect of oral glucose tolerance test on serum osteocalcin and bone turnover markers in young adults","volume":"90","author":"Paldanius","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"B125","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000323368","article-title":"Zoledronic acid treatment in children with osteogenesis imperfecta","volume":"75","author":"Vuorimies","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"B126","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"B128","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1210\/jc.2016-2365","article-title":"Circulating microRNA signatures in patients with idiopathic and postmenopausal osteoporosis and fragility fractures","volume":"101","author":"Kocijan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B129","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mce.2015.10.015","article-title":"Circulating microRNAs as novel biomarkers for bone diseases\u2013complex signatures for multifactorial diseases?","volume":"432","author":"Hackl","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11914-018-0417-0","article-title":"Regulation of bone metabolism by microRNAs","volume":"16","author":"Taipaleenm\u00e4ki","year":"2018","journal-title":"Curr Osteoporos Rep"},{"key":"B131","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1038\/s41598-018-26525-y","article-title":"Circulating microRNAs as potential diagnostic biomarkers for osteoporosis","volume":"8","author":"Mandourah","year":"2018","journal-title":"Sci Rep"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e34641","DOI":"10.1371\/journal.pone.0034641","article-title":"MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e971","DOI":"10.7717\/peerj.971","article-title":"Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis","volume":"3","author":"Meng","year":"2015","journal-title":"PeerJ"},{"key":"B134","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3109\/1354750X.2014.935957","article-title":"Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients","volume":"19","author":"Li","year":"2014","journal-title":"Biomarkers"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/jbmr.2175","article-title":"Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures","volume":"29","author":"Seeliger","year":"2014","journal-title":"J Bone Miner Res"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1080\/15476286.2015.1094600","article-title":"Downregulation of MicroRNA-152 contributes to high expression of DKK1 in multiple myeloma","volume":"12","author":"Xu","year":"2015","journal-title":"RNA Biol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/jbmr.377","article-title":"Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1","volume":"26","author":"Zhang","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1038\/cddis.2013.356","article-title":"miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis"},{"key":"B139","doi-asserted-by":"publisher","first-page":"13906","DOI":"10.1073\/pnas.0804438105","article-title":"A microRNA signature for a BMP2-induced osteoblast lineage commitment program","volume":"105","author":"Li","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1210\/jc.2017-02406","article-title":"Changes of circulating MicroRNAs in response to treatment with teriparatide or denosumab in postmenopausal osteoporosis","volume":"103","author":"Anastasilakis","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B141","doi-asserted-by":"publisher","first-page":"CD005088","DOI":"10.1002\/14651858.CD005088.pub4","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B142","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11914-017-0401-0","article-title":"Long-term bisphosphonate therapy in osteogenesis imperfecta","volume":"15","author":"Biggin","year":"2017","journal-title":"Curr Osteoporos Rep"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1097\/MJT.0000000000000236","article-title":"Efficacy of bisphosphonates on bone mineral density and fracture rate in patients with osteogenesis imperfecta: a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2016","journal-title":"Am J Ther"},{"key":"B144","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1172\/JCI92617","article-title":"Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis","volume":"127","author":"Joeng","year":"2017","journal-title":"J Clin Invest"},{"key":"B145","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000477242","article-title":"PLS3 mutations in X-linked osteoporosis: clinical and bone characteristics of two novel mutations","volume":"88","author":"Kannu","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B146","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1007\/s00198-016-3723-3","article-title":"Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment","volume":"27","author":"Trejo","year":"2016","journal-title":"Osteoporos Int"},{"key":"B147","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"B148","first-page":"183","article-title":"First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI","volume":"12","author":"Semler","year":"2012","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B149","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrd.2016.207","article-title":"Merck &Co. drops osteoporosis drug odanacatib","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3617.","article-title":"Effect of anti-TGF-\u03b2 treatment in a mouse model of severe osteogenesis imperfecta","author":"Tauer","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B151","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14712598.2018.1401607","article-title":"Monoclonal antibodies for treating osteoporosis","volume":"18","author":"Faienza","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"B154","doi-asserted-by":"publisher","first-page":"98673","DOI":"10.1172\/jci.insight.98673","article-title":"Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition","volume":"3","author":"Witcher","year":"2018","journal-title":"JCI Insight"},{"key":"B155","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14259","article-title":"Notum deacylates Wnt proteins to suppress signalling activity","volume":"519","author":"Kakugawa","year":"2015","journal-title":"Nature"},{"key":"B156","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.devcel.2015.02.014","article-title":"Notum is required for neural and head induction via Wnt deacylation, oxidation and inactivation","volume":"32","author":"Zhang","year":"2015","journal-title":"Dev Cell"},{"key":"B157","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yrtph.2016.08.010","article-title":"Carcinogenicity risk assessment of romosozumab: a review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study","volume":"81","author":"Chouinard","year":"2016","journal-title":"Regul Toxicol Pharmacol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.05.001","article-title":"An overview of microRNAs","volume":"87","author":"Hammond","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"B159","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1158\/1078-0432.CCR-14-0069","article-title":"Association study of the let-7 miRNA-complementary site variant in the 3\u2032 untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 clinical trial)","volume":"20","author":"Sha","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2014.08.015","article-title":"Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients","volume":"111","author":"van der Ree","year":"2014","journal-title":"Antiviral Res"},{"key":"B161","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.2147\/IJN.S94689","article-title":"Microarc-oxidized titanium surfaces functionalized with microRNA-21-loaded chitosan\/hyaluronic acid nanoparticles promote the osteogenic differentiation of human bone marrow mesenchymal stem cells","volume":"10","author":"Wang","year":"2015","journal-title":"Int J Nanomed"},{"key":"B162","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm.3026","article-title":"miR-214 targets ATF4 to inhibit bone formation","volume":"19","author":"Wang","year":"2013","journal-title":"Nat Med"},{"key":"B163","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/jbmr.2040","article-title":"Inhibition of miR-92a enhances fracture healing via promoting angiogenesis in a model of stabilized fracture in young mice","volume":"29","author":"Murata","year":"2014","journal-title":"J Bone Miner Res"},{"key":"B164","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1016\/j.biomaterials.2013.03.052","article-title":"The promotion of bone regeneration through positive regulation of angiogenic-osteogenic coupling using microRNA-26a","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"B165","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1167\/iovs.14-14977","article-title":"Repair of canine medial orbital bone defects with miR-31-modified bone marrow mesenchymal stem cells","volume":"55","author":"Deng","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T10:20:46Z","timestamp":1662978046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":165,"alternative-id":["10.3389\/fendo.2019.00070"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00070","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"article-number":"70"}}